HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Ingemansson Selected Research

Sternotomy

1/2014Can post-sternotomy mediastinitis be prevented by a closed incision management system?
8/2011Haemodynamic effects of negative pressure wound therapy when using a rigid barrier to prevent heart rupture.
3/2011Sternum wound contraction and distension during negative pressure wound therapy when using a rigid disc to prevent heart and lung rupture.
3/2011Effects of foam or gauze on sternum wound contraction, distension and heart and lung damage during negative-pressure wound therapy of porcine sternotomy wounds.
1/2011Effects on heart pumping function when using foam and gauze for negative pressure wound therapy of sternotomy wounds.
10/2010Influence on pressure transduction when using different drainage techniques and wound fillers (foam and gauze) for negative pressure wound therapy.
9/2010Wound contraction and macro-deformation during negative pressure therapy of sternotomy wounds.
8/2010Changes in cardiac pumping efficiency and intra-thoracic organ volume during negative pressure wound therapy of sternotomy wounds, assessment using magnetic resonance imaging.
1/2010Changes in cardiac pumping efficiency and intra-thoracic organ volume during negative pressure wound therapy of sternotomy wounds, assessment using magnetic resonance imaging.
9/2009Preventing heart injury during negative pressure wound therapy in cardiac surgery: assessment using real-time magnetic resonance imaging.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Ingemansson Research Topics

Disease

50Wounds and Injuries (Trauma)
02/2015 - 05/2002
16Mediastinitis
01/2014 - 04/2004
11Wound Infection (Wound Infections)
10/2014 - 05/2002
9Heart Rupture
04/2015 - 02/2009
8Hemorrhage
12/2017 - 04/2003
6Rupture
03/2014 - 09/2006
5Bronchiolitis Obliterans Syndrome
11/2017 - 01/2009
5Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 01/2004
4Aortic Dissection
10/2019 - 12/2017
4Thrombosis (Thrombus)
10/2017 - 10/2013
4Death (Near-Death Experience)
10/2017 - 01/2015
4Infections
04/2015 - 05/2002
3Stroke (Strokes)
01/2020 - 09/2016
3Pain (Aches)
01/2012 - 04/2011
2Chronic Obstructive Pulmonary Disease (COPD)
10/2020 - 06/2007
2Cystic Fibrosis (Mucoviscidosis)
10/2020 - 01/2016
2Ventricular Fibrillation
11/2016 - 10/2015
2Edema (Dropsy)
10/2014 - 04/2011
2Fistula
12/2009 - 06/2005
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2004 - 01/2004
1Primary Graft Dysfunction
04/2022
1Neoplasms (Cancer)
10/2020
1Pulmonary Hypertension
10/2020
1Lung Diseases (Lung Disease)
10/2020
1Mental Disorders (Mental Disorder)
10/2020
1Ischemia
09/2016
1Open Fractures (Compound Fracture)
10/2014
1Seroma
10/2014
1Surgical Wound
01/2014
1Inflammation (Inflammations)
12/2011
1Cicatrix (Scar)
04/2011
1Renal Insufficiency (Renal Failure)
12/2009
1Heart Injuries
09/2009
1Migraine Disorders (Migraine)
05/2005
1Hyperemia
11/2004
1Heart Failure
01/2004

Drug/Important Bio-Agent (IBA)

4dicarboxydine (DCD)IBA
10/2017 - 01/2015
4polyurethane foamIBA
12/2011 - 03/2009
4Endothelins (Endothelin)IBA
09/2008 - 01/2004
3Heparin (Liquaemin)FDA LinkGeneric
11/2016 - 10/2013
3Biological ProductsIBA
12/2011 - 10/2010
3acivicin (AT 125)IBA
02/2011 - 09/2006
2Propofol (Diprivan)FDA LinkGeneric
01/2020 - 09/2016
2Sevoflurane (Ultane)FDA LinkGeneric
01/2020 - 09/2016
2C-Reactive ProteinIBA
04/2015 - 05/2002
2Oxygen (Dioxygen)IBA
01/2015 - 05/2005
2ParaffinIBA
02/2011 - 12/2003
2Endothelin Receptors (Endothelin Receptor)IBA
02/2008 - 01/2004
2Messenger RNA (mRNA)IBA
10/2004 - 01/2004
1Prostaglandins DIBA
04/2022
1Hemostatics (Antihemorrhagics)IBA
10/2019
1von Willebrand FactorIBA
06/2019
1recombinant FVIIa (rFVIIa)FDA Link
12/2017
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2017
1SolutionsIBA
10/2017
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2017
1Dihydrotachysterol (AT 10)IBA
01/2016
1Substance PIBA
12/2011
1Calcitonin Gene-Related PeptideIBA
12/2011
1NeuropeptidesIBA
12/2011
1Protect-ItIBA
08/2011
1Anti-Bacterial Agents (Antibiotics)IBA
12/2009
1bone waxIBA
12/2009
1Hematoxylin (Haematoxylon)IBA
11/2009
1Eosine Yellowish-(YS) (Eosin)IBA
11/2009
1Carbon DioxideIBA
05/2005
1Bicarbonates (Hydrogen Carbonate)IBA
05/2005
1Lactic Acid (Lactate)FDA LinkGeneric
05/2005
1Tryptamines (Triptans)IBA
05/2005
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2004
1AngiotensinsIBA
10/2004
1Angiotensin IIIBA
10/2004
1Type 1 Angiotensin ReceptorIBA
10/2004

Therapy/Procedure

59Negative-Pressure Wound Therapy
04/2015 - 05/2002
28Therapeutics
10/2020 - 05/2002
21Sternotomy
01/2014 - 05/2002
8Lasers (Laser)
12/2011 - 11/2004
6Lung Transplantation
04/2022 - 10/2013
4Debridement
02/2011 - 05/2002
3Traction
03/2011 - 09/2006
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2008 - 10/2005
2Warm Ischemia
10/2015 - 01/2015
2Transplantation
01/2011 - 01/2009
2Catheters
10/2010 - 03/2009
1Artificial Respiration (Mechanical Ventilation)
04/2022
1Contraindications
10/2020
1Continuity of Patient Care
01/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
12/2017
1Chest Tubes (Chest Tube)
12/2017
1Ligation
09/2016
1Anesthesia
09/2016
1Inhalation Anesthesia
09/2016
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2015
1Operative Surgical Procedures
10/2014
1Tissue and Organ Harvesting
10/2013
1Protective Devices (Safety Device)
01/2013
1Aftercare (After-Treatment)
11/2009
1Extracorporeal Membrane Oxygenation
06/2007
1Heart Transplantation (Grafting, Heart)
04/2004
1jelonet
12/2003